A dichloromethane extract from twigs and leaves of Murraya exotica produced allosteric potentiation of gamma aminobutyric acid (GABA) induced chloride currents in a microelectrode assay in Xenopus laevis oocytes expressing GABA receptors of α 1 , β 2 , γ 2s subunit composition. The activity was tracked by HPLCbased activity profiling utilizing a zebrafish locomotor activity assay. Osthol (9) was identified as the main active compound. In addition, five other coumarins and four flavonols were identified. Osthol (9) and structurally related coumurrayin (10) were tested in the Xenopus oocyte assay. Compound 9 potentiated GABA A -induced chloride currents by 487 ± 42%, with an EC 50 of 46 ± 10 µM, while 10 showed negligible effects on chloride currents. In silico evaluation of physicochemical properties showed that 9 and 10 had properties that are favorable for oral bioavailability and BBB permeability.
Ionotropic gamma aminobutyric acid (GABA A ) receptors are important inhibitory neurotransmitter receptors in the central nervous system (CNS) [1] . Human GABA A receptors are heteropentameric proteins with numerous combinations of 19 different subunits (α [1] [2] [3] [4] [5] [6] , β [1] [2] [3] , γ 1-3 , δ, π, ε, θ, and ρ 1-3 ) [2] . The most abundant GABA A receptor subtype in the brain is composed of 2 α 1, 2 β 2 and 1 γ 2 subunits [3] . GABA A receptors possess binding sites for the endogenous neurotransmitter GABA, and an allosteric binding site (benzodiazepine binding site) where drugs such as benzodiazepines and other compounds interact and thereby potentiate the effects of the neurotransmitter. Also, there is evidence for additional allosteric binding sites [4] . Currently used benzodiazepines and non-benzodiazepines (e.g. zolpidem) lack of GABA A receptor subtype selectivity and, therefore, possess a number of adverse effects such as sedation and addiction [1, 4] . There is thus a need for new allosteric GABA A receptor modulators with subtype selectivity and ideally novel binding modes.
A structurally diverse range of natural products are known to interact with GABA A receptors in various ways, as orthosteric agonists (e.g. muscimol), as orthosteric antagonists (e.g. bicuculline), as non-competitive channel blockers (e.g. picrotoxin), or as allosteric agonists at the benzodiazepine binding site (e.g. valerenic acid) [5] . Compounds such as piperine interact with a benzodiazepine-independent allosteric binding site [6] . Given the need for novel chemotypes of GABA A receptor modulators, and considering the structural diversity and uniqueness of natural products as compared to synthetic drugs, we screened an in-house library of plant extracts for allosteric modulation of human GABA A receptors (α 1 β 2 γ 2s subunit composition) expressed in Xenopus laevis oocytes [7] . A dichloromethane extract from leaves and twigs of Murraya exotica L. (Rutaceae) enhanced the GABA A -induced chloride ion current (I GABA ) by 102 % when tested at 100 µg/mL. The activity was confirmed in a larval zebrafish locomotor assay [8] . The maximal tolerable concentration (MTC) of the extract was determined, and the MTC (20 µg/mL) used as the highest test concentration. Lowering of pentylenetetrazol (PTZ)-induced larval locomotion was recorded at 5, 10, and 20 µg/mL of extract.
Total distance (in mm) travelled by the larvae within 25 min (5 to 30 min after exposure of larvae to 6 mM PTZ) was recorded and compared with that of the PTZ-only group ( Figure 1A) . The extract lowered PTZ-induced locomotion in a concentration-dependent manner. At the highest concentration of 20 µg/mL locomotion was 68.2 ± 3.4% of the PTZ-only group (red bar). The positive control NPC Natural Product Communications 2019 Vol. 14 No. 1 41 -45 diazepam (4 µM) lowered the larval locomotion to 72.0 ± 2.4%. Patterns of larval movement were visualized by plotting the distance travelled from 5 to 30 min after exposure to 6 mM PTZ, whereby 5-min intervals were recorded ( Figure 1B) . The assay was also performed with 3 mM PTZ to ensure that lowering of larval locomotion in the later phases of observation was not due to toxicity ( Figure 1C and 1D) [8] . The extract thus lowered PTZ-provoked locomotion over the entire tracking period [9] . Given that zebrafish larvae used in the assay (7 days postfertilization, dpf) possess a functional blood-brain barrier (BBB) [10, 11] , one could thus assume that the activity seen in the initial Xenopus oocyte assay was due to BBB permeable compounds with drug-like properties [12, 13, 14] . As a next step, HPLC-based activity profiling of the extract was performed with the aid of the larval zebrafish locomotor assay [8] . The HPLC chromatogram recorded at 315 nm and the corresponding activity profile are shown in Figure 2 . A decrease of larval locomotion was found for fraction F6 (18 to 21 min). The active time-window showed two main peaks (t R = 19.9 min and t R = 20.8 min). The latter was identified after preparative isolation as osthol (9) . The earlier eluting peak was a mixture of several structurally related compounds which could not be purified due to the limited amount of material. However, the UV spectrum and NMR data of the mixture were indicative of coumarins [15] . In addition, compounds outside of the active time-window were isolated to obtain preliminary information on structural features responsible for activity/inactivity [6] . Five coumarins, osthenon (1), hainanmurpanin (2), meranzin (4), phebalosin (6), and coumurrayin (10) Osthol (9) from the active time-window, and methoxy derivative 10 from the later eluting inactive fraction F7 were submitted to in vitro automated two-microelectrode voltage clamp assay on Xenopus oocytes expressing α 1 β 2 γ 2s receptors. Compound 9 showed considerable GABAergic activity (EC 50 = 46 ± 10 µM, potentiation of I GABA by 487 ± 42%), whereas 10 was inactive at concentrations up to 300 µM. The positive control diazepam (1 µM) enhanced I GABA by 231.3 ± 22.6%. Osthol (9) had been recently identified in a screening of a compound library of natural coumarins as a positive allosteric GABA A receptor modulator targeting the benzodiazepine binding site [25] .
Important physicochemical and ADME properties as defined by Lipinski [12, 13] and Veber [14] were calculated for 9 and 10 to possibly explain the lack of activity of 10 (Table 1) . However, the data indicated that both compounds fulfilled criteria for oral bioavailability and permeability of the blood-brain-barrier (BBB). In the case of active osthol (9), BBB permeation was supported by the observed activity in the larval zebrafish assay. However, the lack of activity of 10, as compared to active 9, could not be explained by the pharmacophore model that has been proposed for coumarins [25] .
As to polymethoxyflavones 3, 5, 7 and 8, their lack of activity indirectly confirmed earlier findings that for simple natural flavones and flavonols the presence of free phenolic groups is required for interaction with ionotropic GABA receptors [26] [27] [28] .
Experimental
General: Pentylenetetrazol (PTZ) (purity ≥ 98 %) was from SigmaAldrich, and diazepam (purity ≥ 98 %) was from Lipomed. HPLCgrade acetonitrile (Scharlau) and water (Barnstead EASY-pure II water purification system) were used for HPLC separations. HPLC solvents contained 0.1% formic acid (Scharlau) for analytical separations. DMSO (Scharlau) was used for dissolving the samples for HPLC analysis. Deuterated solvents for NMR were purchased from Armar Chemicals. Solvents used for extraction, column chromatography, centrifugal partition chromatography (CPC), and recrystallization were of technical grade (Romil Pure Chemistry) and were redistilled before use. Silica gel (63-200 µm, Merck) was used for column chromatography. Profiling
Optical rotation was measured with a P -2000 digital polarimeter (Jasco) equipped with a sodium lamp (589 nm) and a 10 cm temperature-controlled microcell.
NMR spectra were recorded with a Bruker Avance III spectrometer operating at 500.13 MHz for 1 H and 125.77 MHz for 13 C. 1 H NMR experiments and 2D homonuclear and heteronuclear NMR spectra were measured with a 1 mm TXI probe at 18°C. 13 C NMR spectra were obtained in 3 or 5 mm tubes at 23°C. Data were analyzed using ACD/Spectrus Processor 2017.1.3. HPLC-PDA-MS analyses were performed with a Shimadzu LC-PDA-MS/MS instrument consisting of a degasser, quaternary pump (LC-20AD), column oven (CTO-20AC), PDA detector (SPD-M20A), and triple quadrupole mass spectrometer (LCMS-8030), connected via a Tsplit to an ELSD 3300 detector (Alltech). A SunFire C18 column (3.5 µm, 3.0 x 150 mm) equipped with a guard column (3.0 x 10 mm) (Waters) was used for analytical separations. Data acquisition and processing were performed using lab solution software (Shimadzu).
Centrifugal partition chromatography (CPC) was performed on an Armen Instrument with coil volume 100 mL connected to a pump model 210 (Varian), 218 UV detector (Varian) and a fraction collector model 704 (Varian).
Flash chromatography was carried out on a Sepacore MPLC system consisting of two C-605 pumps, C-635 UV detector, and C-660 fraction collector (all Büchi), or with a Puriflash 4100 system (Interchim). A glass column (70 x 460 mm), and prepacked silica gel cartridges (Interchim) 12 g (50 µm), 40 g (15 µm) and 125 g (30 µm) were used.
Semi-preparative HPLC was carried out with a Waters 2690 instrument consisting of a degasser, binary high pressure mixing pump, column oven, and a Waters 996 photodiode array detector. A SunFire Prep C18 column (5 µm, 10 x 150 mm) equipped with a guard column (10 x 10 mm) (Waters) was used for separation.
Evaporation of micro-fractions was done with a Genevac EZ-2 plus vacuum centrifuge (Avantec).
The movement of zebrafish larvae was tracked with DanioVision observation chamber equipped with an IR sensitive camera and a temperature controller unit (Noldus Information Technology). The locomotor activity was analyzed with EthoVision XT11 software (Noldus Information Technology). 
Two-microelectrode voltage clamp assay with Xenopus laevis oocytes:
Recombinant GABA A receptors (α 1 β 2 γ 2s ) were expressed in X. laevis oocytes by cRNA injection, as previously described [28] . Two-microelectrode voltage clamp measurements were performed between day 1 and 5 after cRNA injection, using a TURBO TEC 03X amplifier (npi Electronic) at a holding potential of -70 mV. Data acquisition was with pCLAMP 10 software (Molecular Devices). Currents were low-pass filtered at 1 kHz and sampled at 3 kHz. The bath solution contained 90 mM NaCl, 1 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , and 5 mM HEPES (pH 7.4). Electrode filling solution contained 3 M KCl. Test solutions (100 µL) were applied to the oocytes at a speed of 200 µL/s by means of the Screening Tool automated fast perfusion system (npi Electronic). GABA EC [4] [5] [6] was determined through a concentration-response experiment with 0.1 to 1 mM GABA solutions. Stock solutions of tested extract (10 mg/mL) and pure compounds (100 mM) in DMSO were diluted with a bath solution containing GABA EC 4-6 to obtain appropriate working solutions according to a validated protocol. Enhancement of the I GABA was defined as (I GABA + Comp /I GABA ) -1, where I(GABA + Comp) is the current response in the presence of a given compound, and I GABA is the control of the GABA-induced chloride current. Data were analyzed using Origin 7.0 SR0 software (OriginLab Corporation) and are given as the mean ± SE of at least two oocytes from ≥ 2 batches. Diazepam (purity ≥ 98%; Sigma) was used as a positive control at 1 µM.
Zebrafish larvae locomotor activity model: Experiments were approved by the Kantonales Veterinaeramt Basel-Stadt (license number 1995 continuation; approval date 03 February, 2015), and conducted in accordance with EU directive 2011/63/EU. Wild-type zebrafish of the ABC × TU strain were kept under standard conditions [29] . Fertilized eggs were collected via natural spawning, and incubated at 28.5 °C in E3 medium containing 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2 , and 0.33 mM MgSO 4 in water (0.5 mL methylene blue 0.05% w/v was added to 1 liter medium as a disinfectant, and pH was corrected to 7.4 by K 2 CO 3 0.5 M). Stock solution of the extract (10 mg/mL in DMSO) was diluted with E3 medium to obtain the appropriate working solution. Toxicity assessments were performed prior to the activity screening. Larvae (6 dpf) were placed in 96-well plates (1 larva per well), and aliquots of 50 µL working solutions were spiked into each well to afford a final volume of 250 µL. Larvae (n = 12) were incubated with the extract at 50, 25, 12.5, and 6.25 µg/mL. Locomotor impairments, including loss of larval response after a light touch of the tail, loss of posture, body deformation, and death were monitored and compared with the blank (same number of untreated larvae) after 3, 6, and 24 h. After the first toxicity assessment, intermediate concentrations were tested to accurately define the MTC at which not more than 2 of 12 larvae were impaired. For activity screening, MTC was considered as the highest test concentration. The lower concentrations were obtained by serial dilutions. Larvae (7dpf, n = 16) were incubated for 3 h at 28.5 °C with the test solutions. Then, 20 µL of PTZ solution were added to each well to reach a final test concentration (6 mM or 3 mM). Microplates were placed in the movement-tracking chamber. Tracking of the larval movements started after 5 min, and continued until 30 min. Total distance travelled by the larvae within 25 min (between min 5 and 30) was considered as the total locomotor activity. Patterns of larval movements were obtained by plotting movement vs. time, whereby total distance traveled was calculated over 5-min intervals. A PTZonly group (16 larvae treated only with PTZ) and a blank group (16 larvae maintained only in the medium) were placed in each microplate. Diazepam (4 µM) was used as the positive control. All tests were repeated in two independent experiments (n = 32). Statistical analyses were performed with IBM SPSS Statistics version 20 using the Kruskal-Wallis test followed by the MannWhitney test to determine significant differences between treatment groups and the PTZ only group.
Micro-fractionation for activity profiling: HPLC-based activity profiling of dichloromethane extract M. exotica was performed with a zebrafish larvae locomotor activity assay as previously reported [7, 8, 30] with minor modifications. Micro-fractionation was carried out in two identical repeats whereby in each of those, 36 µL extract (10 mg/mL in DMSO) was injected onto an analytical HPLC column (SunFire C18, 3.5 µm, 3 x 150 mm) eluted with H 2 O + 0.1% formic acid (A), and MeCN + 0.1% formic acid (B); 20→90% B (0-24 min), 100% B (24-29 min). The flow rate was 0.4 mL/min. Three-min micro-fractions between t R 3 and 27 min were collected into a 96-well deep-well plate. Corresponding micro-fractions from the two injections were combined. After drying the plate in an EZ-2 Plus evaporator (GeneVac), micro-fractions in the wells were dissolved with 11.25 µL of DMSO, and the plate was shaken at 1400 rpm for 30 min for complete dissolution (stock solutions). Afterwards, E3 medium was added to each stock solution up to a final volume of 900 µL. Corresponding micro-fractions from two injections were combined (working solutions). Aliquots of 50 µL of working solutions were added to each well of a 96-well microliter plate containing one zebrafish larva and 200 µL of E3 medium (final DMSO concentration of 0.5%). Sixteen larvae were used for testing of each micro-fraction, and the activity was assessed in duplicate experiments (n = 32).
Extraction and isolation: Powdered M. exotica leaves and twigs (135 g) were extracted with 2 x 300 mL DCM for 24 h each under stirring at room temperature. The extracts were combined and evaporated under reduced pressure to afford 22.5 g of dry extract. The extract was chromatographed on a silica gel column (70 x 460 mm) at a flow rate of 25 mL/min, using a step gradient (n-hexane, n-hexane/EtOAc, EtOAc, EtOAc/MeOH and MeOH). A total of 43 fractions were collected. Compounds detected in the active time window of the HPLC activity profiling were localized in fractions 13 (90.1 mg) and 14 (160.0 mg). Both fractions were further separated on a silica gel cartridge 40 g [n-hexane/EtOAc (9:1, 0. In silico predictions: Physicochemical and ADME properties for 9 and 10 were calculated with QikProp (QikProp, version 4.6, Schrödinger, LLC, 2015) and Percepta (ACD/Labs, ACD/Percepta Platform, version 12.10, 2012). These software packages use trained QSAR models for calculating predefined physicochemical descriptors for drug-likeness (according to Lipinski's rule of five [12, 13] and Veber's rule [14] ) and for determination of properties that are relevant from a pharmacokinetic viewpoint (e.g. plasma protein binding, Caco-2 permeability, and Log BB)
Supplementary data: Spectroscopic data of compounds 1-10, including 1 H NMR data and 13 C NMR data (extracted from HSQC-DEPT and HMBC spectra for compounds 1,2,4,7,9, and 10)
